Marjorie Perloff, MD

Articles by Marjorie Perloff, MD

Strategies for Identification and Clinical Evaluation of Promising Chemopreventive Agents

ByGary J. Kelloff, MD,Ernest T. Hawk, MD, MPH,Charles W. Boone, MD, PhD,Susan G. Nayfield, MD, MSC,Marjorie Perloff, MD,Vernon E. Steele, PhD, MPH,Ronald A. Lubet, PhD,Caroline C. Sigman, PhD

Strategies for chemopreventative drug development are based on the use of well-characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable cohorts for efficacy studies. Since

Latest Updated Articles